More perspectives from experienced operators on the great build vs. buy question for fundamental technology used by digital health cos
Part 1 in our founder's guide to financing your women's health startup
What is keeping employers up at night going into 2025? A conversation with Chris Michalak
My takeaway from today’s news that the company is filing for bankruptcy
Guest author Halle Tecco’s breakdown of how the companies valued at more than $1b at the peak are faring — TLDR, the results surprised her!
A few thoughts...
And what are the pros and cons?
I caught up with Conceivable Life Sciences’ Joshua Abram to understand the political landscape and its impact on reproductive health
Some digital health companies are getting more targeted with their approach
State of the union, and where we go from here
Let’s get real about the alliance between U.S. health care and employment
Plus, some thoughts about Transcarent buying Accolade!
Because so many of you asked for it!
Things have gotten a little better in digital health VC land, but it’s still challenging out there!
Health care VCs are flocking to AI - and it’s all starting to feel a lot like crypto
I teamed up with two health policy experts to explore the bull and bear case.
The company closed up shop abruptly this week.
Lessons learned after a strategy shift featuring Brightline CEO Naomi Allen and investor Alyssa Jaffee
With Tom Cassels, who’s sat on plenty of boards as an independent director
One longtime women's health investor weighs in...
Important new data is out today indicating that might be the case — and for the very reason you might expect!
Our guide to the new regulation, plus the biggest opportunities and the challenges
Health care is a tough market, but there are invariably going to be big opportunities, according to Maveron's Jason Stoffer
The incumbents have gotten a lot bigger since 2019, so digital health startups will need to change their strategy to get acquired.
Build for the needs of a community, not a single condition
